In the pharmaceutical industry, Bromocriptine Mesylate tablets (commonly manufactured in 0.8 mg, 2.5 mg, and 5 mg strengths) are a potent ergot derivative that acts as a dopamine D2 receptor agonist. As a pharmacist, I view Bromocriptine as a versatile endocrine and neurological regulator that bridges the gap between hormone management and movement disorders.
Primary Clinical Uses
Hyperprolactinemia-Associated Disorders: The primary treatment for conditions caused by high prolactin, including amenorrhea (loss of menstrual cycle), galactorrhea (unexplained milk production), and infertility.
Prolactinomas: Used to shrink prolactin-secreting pituitary adenomas (benign tumors).
Acromegaly: Indicated to reduce elevated Growth Hormone (GH) levels in patients who have not responded sufficiently to surgery or radiation.
Parkinson’s Disease: Used as an adjunct to Levodopa/Carbidopa to manage the signs and symptoms of idiopathic or postencephalitic Parkinson’s.
Type 2 Diabetes Mellitus: A specific quick-release formulation (Cycloset) is used to improve glycemic control by modulating circadian rhythm-mediated glucose metabolism.
Mechanism of Action
Bromocriptine acts by directly stimulating postsynaptic dopamine D2 receptors in the brain.
In the Pituitary Gland: It mimics the action of dopamine (the “prolactin-inhibiting factor”), thereby suppressing the synthesis and secretion of prolactin from the anterior pituitary.
In the Corpus Striatum: For Parkinson’s, it compensates for the lack of endogenous dopamine, helping to restore the balance required for smooth muscle movement and coordination.
The Manufacturer’s Perspective: Formulation & Export
From a manufacturing and global trade standpoint, Bromocriptine is a high-precision, specialty molecule:
API Sensitivity: Bromocriptine Mesylate is highly sensitive to light and oxidation. As a WHO-GMP manufacturer, we utilize specialized light-resistant coating and amber-colored packaging to ensure the API does not degrade during its shelf life.
Micronization: Given the low dosage (2.5 mg), we employ micronization techniques to ensure uniform particle size, which is critical for consistent dissolution and absorption.
Global Export Profile: This is a high-value niche product for B2B distributors catering to endocrinology and neurology clinics. Our Mumbai facility is equipped to provide the CTD/eCTD Dossiers required for registration in regulated and semi-regulated markets.
Stability for Export: We provide stability data for Zone IVb conditions, ensuring that the product remains potent even when exported to hot and humid regions in Africa and Southeast Asia.